GSK plc

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 11:35:04 2025-07-14 EDT			5-day change	1st Jan Change
1,424.50 ^GBX	+1.14%		+2.08%	+5.79%

10:21am	GSK Viiv Extends Cabotegravir Licensing Deal to Include HIV Treatment	MT
10:07am	GSK seeks FDA nod for expanded use of RSV vaccine in adults	RE

GSK : Goldman Sachs reiterates its Neutral rating

Published on 2025-05-14 at 07:13

Goldman Sachs analyst Rajan Sharma maintains his Neutral opinion on the stock. The target price is slightly modified from 1570 to 1560 GBX.

Latest news about GSK plc

GSK Viiv Extends Cabotegravir Licensing Deal to Include HIV Treatment	10:21am	MT
GSK seeks FDA nod for expanded use of RSV vaccine in adults	10:07am	RE
Global markets live: Tesla, Gilead, Kenvue, Amazon, Bayer…	09:57am
ViiV expands licence to allow generic HIV treatment production for low-income countries	09:01am	RE
GSK Seeks FDA Approval to Expand RSV Vaccine Use to At-Risk Adults Aged 18-49	05:55am	MT
GSK: seeks FDA approval to expand Arexvy indication	04:43am	CF
GSK seeks FDA green light for expanded use of RSV vaccine Arexvy	03:22am	AN
DCC sells unit; South32 warns of Mozal impairment	02:55am	AN
US FDA Accepts GSK's Application to Expand Indication for RSV Vaccine	02:26am	MT
GSK submits Arexvy for adults 18-49 air to FDA	02:20am	RE
GSK seeks FDA nod for expanded use of RSV vaccine in adults	02:13am	RE
Sector Update: Health Care Stocks Slide Friday Afternoon	07-11	MT
FTSE 100 eases from record levels amid soft GDP	07-11	AN
European Equities Traded in the US as American Depositary Receipts Drop Sharply in Friday Trading	07-11	MT
FDA May Fast Track Drug Reviews for Lower US Prices	07-11	MT
FDA May Fast Track Drug Reviews for Lower US Prices, Bloomberg Reports	07-11	MT
Sector Update: Health Care Stocks Decline Pre-Bell Friday	07-11	MT
GSK, Pfizer, Boehringer Ingelheim Win Reversal in Zantac Cancer Case	07-11	MT
Jet2 raised to 'buy'; Investec cuts Pagegroup	07-11	AN
Delaware Supreme Court sides with Zantac drugmakers over cancer evidence	07-10	RE
Sector Update: Health Care Stocks Rise Late Afternoon	07-10	MT
Delaware Supreme Court sides with Zantac drugmakers over evidence	07-10	RE
Sector Update: Health Care Stocks Rise Thursday Afternoon	07-10	MT
Britain's FTSE 100 notches record close, buoyed by miners	07-10	RE
European Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading	07-10	MT

GSK plc is a global biopharma company. The Companyâs segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. Its product areas include vaccines, specialty medicines, and general medicine. It is also focused on addressing the unmet treatment needs of patients with respiratory and inflammatory conditions. Its vaccine portfolio includes over 20 vaccines that help to protect people from a range of diseases and infections, including meningitis, shingles and flu, among others. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease, antibiotics, and medicines for skin diseases. It is advancing oligonucleotide therapeutics in chronic hepatitis B and steatotic liver disease as well as other therapeutic areas beyond liver disease.

Employees

68,629

Sector

Pharmaceuticals

Calendar

07-15 - International AIDS Society Conference - Abstract #OAB0104

More about the company